Project Abstract

Although my topic of study may seem obscure (the α6β2β3 nAChR subtype), it is actually critical in rewarding nicotine addiction. When the genes for this specific receptor subtype are inactivated, mice have been shown to stop self-administering nicotine because they consequently lack the receptors necessary to release dopamine (the “feel-good” neurotransmitter behind many addictions) upon nicotine administration. Similarly disabling these receptors in humans could have a remarkable impact on smoking cessation. Unfortunately, we are not yet certain because, as of yet, these receptors are extremely difficult to recreate in frog oocytes (egg cells), which are typically used to study receptor function due to their manipulability. Dr. Chang hypothesizes that in order to successfully express the genes for these receptors in frog oocytes, they must be inserted alongside genes coding for opioid receptors. We can test this through simple DNA injection or more complex techniques such as electroporation (literally “shocking” the cells into taking in the DNA).  If this hypothesis proves successful, further research can determine the function of these apparently critical receptors and how to utilize them to combat nicotine addiction. 

Comments

Post a Comment

Popular posts from this blog

Week 6

Image
Hey, everyone! Short post this week, as I only went in on Monday and took the rest of the week off for spring break. I retrieved the plate that I had inoculated on Friday, which now had several bacterial colonies visibly growing. If you remember, these bacteria contained the one type of DNA which hadn't worked last week. I amplified that DNA using PCR, which took up most of the day. I then ran what is hopefully the last-ever gel on the products and, to my relief, the results were successful! Now that we finally had all the DNA we needed, I chose two colonies from each plate (based on previous gels) and cultured them. The last step will be to isolate the DNA and send it to another lab for sequencing, which will serve as the final confirmation. See you next week!
Read more

Week 5

I nearly finished the cloning process this week but ran into my first bout of trouble. No project would be fun without a challenge, though, which is exactly what I encountered. Most of the week was spent diagnosing then attempting a solution-- whether it works remains to be seen when I return! -------------------------------------------------------------------------------------------------------------------------- On Monday, I ran a gel on the DNA that was sitting in the fridge over the weekend (if you haven't noticed, I do a lot  of gel electrophoresis, as the DNA has to be verified as correct after every step of the FastCloning process). Oddly, nothing showed up in the gel. I checked everything about the gel setup itself (including the agarose solution, this time), but nothing was wrong, meaning the DNA was the culprit. Dr. Chang suggested that I amplify the DNA-- maybe the issue was that there simply wasn't enough of it. I spent the rest of the afternoon preparing t
Read more

Week 4

Image
I got right back to work this week after my mentor arrived from Minneapolis on Monday. The final DNA sequences had finally arrived while we were out, so we began the process of molecular cloning: inserting the sequences into plasmids (larger, circular DNA fragments that carry the desired sequences), coaxing some bacteria into taking in and naturally reproducing the plasmids, and finally purifying the "cloned" DNA product. This can be done in a variety of ways, but many traditional methods involve expensive kits or have an unacceptable risk of mutation. So we used FastCloning, an inexpensive and effective method that my mentor developed and published in 2011. It carries that name because it is faster than the aforementioned methods; however, as I was about to discover, it is still very time-consuming (at least with my lack of experience). This one's a bit of a doozy; consider it as a supplement to last week's incredibly short one. ---------------------------------
Read more